AU2001276437A1 - Use of polysulphated cyclodextrins for treating osteoarthritis - Google Patents
Use of polysulphated cyclodextrins for treating osteoarthritisInfo
- Publication number
- AU2001276437A1 AU2001276437A1 AU2001276437A AU7643701A AU2001276437A1 AU 2001276437 A1 AU2001276437 A1 AU 2001276437A1 AU 2001276437 A AU2001276437 A AU 2001276437A AU 7643701 A AU7643701 A AU 7643701A AU 2001276437 A1 AU2001276437 A1 AU 2001276437A1
- Authority
- AU
- Australia
- Prior art keywords
- treating osteoarthritis
- polysulphated
- cyclodextrins
- polysulphated cyclodextrins
- osteoarthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to the method of using polysulphated cyclodextrins or addition salts thereof for use in the treatment of arthrosis, and pharmaceutical compositions thereof.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0009272 | 2000-07-17 | ||
FR0009272A FR2811572B1 (en) | 2000-07-17 | 2000-07-17 | USE OF POLYSULFATED CYCLODEXTRINS FOR THE TREATMENT OF ARTHROSIS |
PCT/FR2001/002253 WO2002005826A1 (en) | 2000-07-17 | 2001-07-12 | Use of polysulphated cyclodextrins for treating osteoarthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001276437A1 true AU2001276437A1 (en) | 2002-01-30 |
Family
ID=8852528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001276437A Abandoned AU2001276437A1 (en) | 2000-07-17 | 2001-07-12 | Use of polysulphated cyclodextrins for treating osteoarthritis |
Country Status (13)
Country | Link |
---|---|
US (1) | US6930098B2 (en) |
EP (1) | EP1301192B1 (en) |
JP (1) | JP4960568B2 (en) |
AT (1) | ATE421326T1 (en) |
AU (1) | AU2001276437A1 (en) |
CA (1) | CA2416369C (en) |
CY (1) | CY1108980T1 (en) |
DE (1) | DE60137506D1 (en) |
DK (1) | DK1301192T3 (en) |
ES (1) | ES2322794T3 (en) |
FR (1) | FR2811572B1 (en) |
PT (1) | PT1301192E (en) |
WO (1) | WO2002005826A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005054446A2 (en) * | 2003-12-02 | 2005-06-16 | Universiteit Gent | Use of polysulphated alginate in cellular matrices |
EP2331581A1 (en) * | 2008-09-22 | 2011-06-15 | Arcarios B.V. | Carboxyethylated cyclodextrin polysulfates useful as medicaments |
EA201270739A1 (en) | 2010-03-24 | 2013-02-28 | Аркариос Бв | SUBSTITUTED CYCLODEXTRIN DERIVATIVES, SUITABLE AS INTERMEDIATE PRODUCTS FOR OBTAINING BIOLOGICALLY ACTIVE MATERIALS |
ITMI20132116A1 (en) | 2013-12-18 | 2015-06-19 | Apharm Srl | ASSOCIATION OF GLYCOSAMINOGLICANS AND CYCLODESTRINES |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4247535A (en) * | 1979-11-05 | 1981-01-27 | American Cyanamid Company | Modified cyclodextrin sulfate salts as complement inhibitors |
US4258180A (en) * | 1979-11-05 | 1981-03-24 | American Cyanamid Company | C6-Modified cyclodextrin sulfate salts as complement inhibitors |
CA1333363C (en) * | 1988-01-19 | 1994-12-06 | Judah Folkman | Angiogenesis inhibitor comprising fumagillin |
ES2067854T3 (en) * | 1990-03-15 | 1995-04-01 | Tanabe Seiyaku Co | CYCLODEXTRIN DERIVATIVE POLYSULPHATE AND PROCEDURE FOR PREPARING THE SAME. |
US5100878A (en) * | 1990-05-07 | 1992-03-31 | American Maize-Products Company | Blocking the effect of teratogens on a fetus |
KR930703364A (en) * | 1991-01-30 | 1993-11-29 | 엥겔하르트, 라피체 | Low molecular weight sulfated poly-β-2, 6-fructofuranoic acid and its use for treating degenerative joint disorder |
EP0612249A4 (en) * | 1991-11-11 | 1995-11-08 | Univ Pennsylvania | Methods of inhibiting restenosis. |
US5872109A (en) * | 1995-02-07 | 1999-02-16 | Shiseido Company, Ltd. | Anti-inflammatory agent |
US5843920A (en) * | 1996-09-16 | 1998-12-01 | Biocell Technology, Llc | Anionic saccharides for extraction of anti-angiogenic protein from cartilage |
-
2000
- 2000-07-17 FR FR0009272A patent/FR2811572B1/en not_active Expired - Fee Related
-
2001
- 2001-07-12 DE DE60137506T patent/DE60137506D1/en not_active Expired - Lifetime
- 2001-07-12 ES ES01954083T patent/ES2322794T3/en not_active Expired - Lifetime
- 2001-07-12 US US10/333,226 patent/US6930098B2/en not_active Expired - Fee Related
- 2001-07-12 AU AU2001276437A patent/AU2001276437A1/en not_active Abandoned
- 2001-07-12 DK DK01954083T patent/DK1301192T3/en active
- 2001-07-12 EP EP01954083A patent/EP1301192B1/en not_active Expired - Lifetime
- 2001-07-12 AT AT01954083T patent/ATE421326T1/en active
- 2001-07-12 WO PCT/FR2001/002253 patent/WO2002005826A1/en active Application Filing
- 2001-07-12 PT PT01954083T patent/PT1301192E/en unknown
- 2001-07-12 CA CA002416369A patent/CA2416369C/en not_active Expired - Fee Related
- 2001-07-12 JP JP2002511758A patent/JP4960568B2/en not_active Expired - Fee Related
-
2009
- 2009-04-14 CY CY20091100441T patent/CY1108980T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2004503594A (en) | 2004-02-05 |
PT1301192E (en) | 2009-04-24 |
EP1301192A1 (en) | 2003-04-16 |
ES2322794T3 (en) | 2009-06-29 |
DK1301192T3 (en) | 2009-05-18 |
FR2811572A1 (en) | 2002-01-18 |
JP4960568B2 (en) | 2012-06-27 |
ATE421326T1 (en) | 2009-02-15 |
US6930098B2 (en) | 2005-08-16 |
WO2002005826A1 (en) | 2002-01-24 |
CA2416369C (en) | 2008-07-15 |
CA2416369A1 (en) | 2002-01-24 |
CY1108980T1 (en) | 2014-07-02 |
FR2811572B1 (en) | 2003-04-18 |
US20030109493A1 (en) | 2003-06-12 |
EP1301192B1 (en) | 2009-01-21 |
DE60137506D1 (en) | 2009-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005055944A3 (en) | Oligosaccharide compositions and use thereof in the treatment of infection | |
PT1420801E (en) | Use of fucans in the treatment of adhesions, arthritis and psoriasis | |
PL1654253T3 (en) | Substituted 3-pyrrolidin-indole derivatives | |
PT1411908E (en) | TREATMENT OF INFECTIONS OF THE | |
RS49756B (en) | Use of xenon for preparing a pharmaceutical preparation for treating neurointoxications | |
MY133732A (en) | Sulfonylcarboxamide derivatives, process for their preparation and their use as medicines | |
PL349028A1 (en) | Cancer treatment composition and method using natural plant essential oils | |
EP1670450B8 (en) | Pharmaceutical compositions and method of using levodopa and carbidopa | |
BR0114576A (en) | Compound, pharmaceutical composition, use of a compound, method of treating a disease state and process for preparing a compound | |
WO2002041837A3 (en) | Treatment of mucositis | |
WO2002040702A3 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
TW200509949A (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
DE602004017871D1 (en) | PREPARATIONS FOR THE TREATMENT OF ARTHRITICAL APPEARANCE | |
WO2003106384A3 (en) | Novel boronic chalcone derivatives and uses thereof | |
ATE334690T1 (en) | COMPOSITIONS FOR THE TREATMENT OF CONNECTIVE TISSUE CONTAINING A FERRIC ION AND ASCORBATE | |
RS50148B (en) | Use of docetaxel for treating hepatocellular carcinoma | |
WO2001015677A3 (en) | Use of 5-ht1b/1d agonists to treat otic pain | |
CY1108980T1 (en) | USE OF POLYSULPHOLIC CYCLEDEXRINE FOR ARTHRITIS TREATMENT | |
NO20062229L (en) | Agent and method of treating cancer comprising strontium, amino acid (s) and mineral agent (s) | |
MXPA06007007A (en) | Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours. | |
WO2001080894A3 (en) | Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies | |
BR0111785A (en) | Compositions and methods for treating candidiasis | |
ATE274513T1 (en) | COMPOUNDS AND METHODS FOR TREATING PAIN | |
AU2002347984A1 (en) | Use of norepinephrine reuptake inhibitors for the treatment of tic disorders |